IP Library › Granted Patent US 11,530,250
Granted Patent B2
US 11,530,250 · App. 16/980,579 · Granted Dec 20, 2022

Tyrosine-specific functionalized insulin and insulin analogs

Inventors: Ahmet Kekec (Hoboken, NJ); Nancy Jo Kevin (East Brunswick, NJ); Bing Li (Towaco, NJ); Songnian Lin (Holmdel, NJ); Craig A. Parish (Tenafly, NJ); Weijuan Tang (Scotch Plains, NJ)
Assignee: MERCK SHARP & DOHME LLC
C07K14/62C07K1/1077
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,530,250
App. No.
16/980,579
Granted
Dec 20, 2022
Kind
B2
Abstract

The present invention relates to tyrosine-specific functionalized insulin analogs and processes of making such tyrosine-specific functionalized insulin analogs using R-3H-1,2,4-triazoline-3,5-(4H)diones (PTAD).

Claims (1)

1. A compound, or pharmaceutically acceptable salt thereof, selected from:

Assignments (2)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2020
From: KEKEC, AHMET; KEVIN, NANCY JO; LI, BING; LIN, SONGNIAN; PARISH, CRAIG A.; TANG, WEIJUAN
To: MERCK SHARP & DOHME CORP.
Reel/Frame 053760/0101 →